Universal Navigation

• Emory University |
• Emory Healthcare |
• Woodruff Health Sciences Center

• Emory Sites
• People Directory

• Research

  Ground breaking, multidisciplinary basic science and clinical research at Emory Eye Center focuses on the prevention, diagnosis and treatment of eye diseases. Our research program is one of the top rated in the country; our researchers are pioneers in new developments in vision care.

  The Eye Center established the Laboratory for Eye Research, the first of its kind in the Southeast in 1964. The early laboratory housed leading scientists who conducted research on the causes and treatment of glaucoma and cataracts.

  A number of “firsts” have occurred at the Eye Center, many during the past 20 years: pivotal clinical trials, innovative treatments and procedures for numerous vision disorders.

  Today's research goal is the translation of laboratory findings into treatments for eye diseases and for the prevention of blindness. Our researchers have a profound commitment to studying age-related macular degeneration. Laboratory and clinical research includes antioxidants, new drug delivery systems, retinal cell transplantation, gene therapy, and retinal translocation surgery.

  Ophthalmology research is supported by current NIH funding of $23.8 million. A $2 million 2011 Core Grant enables the Center to continue research for five years.  A $1,080,550 NIH Training Grant supports four pre-doctoral and one post-doctoral fellows.

  P. Michael Iuvone, PhD, directs research at the Eye Center. Scientific faculty include 11 PhDs, 11 post-doctoral fellows, and nine researchers who hold joint appointments in the Department of Ophthalmology and other Emory departments. Recognition for the Center's prestigious research faculty includes:

  * PhDs Henry Edelhauser (former research director), John Nickerson, Iuvone, and Hans Grossniklaus, MD, MBA, were tapped as Association for Research in Vision and Ophthalmology (ARVO) inaugural fellows.

  * Jeffrey Boatright, PhD, was elected president of ARVO, the premier vision research organization in the country.

  * Iuvone was awarded the Senior Scientific Investigator Award by the Research to Prevent Blindness (RPB).

  * Chair Timothy W. Olsen, MD, received the 2010 Macula Society Young Investigator Award.

  * Edelhauser, was named the Charles D. Kelman Innovator's Lecturer by the American Society of Cataract and Refractive Surgeons (ASCRS), and he and Georgia Tech professor Mark Prausnitz received a patent on their microneedle apparatus to deliver drugs to the back of the eye.

  EEC researchers published the first all-digital, peer-reviewed life sciences journal, Molecular Vision, which has become the #2 vision sciences journal in the world. Seen as an exemplar by the NIH Library, this open access journal is freely available to authors and readers and indexed by all major services.

  Research Faculty

  J.H. Boatright, PhD
  Vincent Thomas Ciavatta, PhD
  Henry F. Edelhauser, PhD
  Rashidul Haque, PhD
  P. Michael Iuvone, PhD
  John M. Nickerson, PhD
  Machelle T. Pardue, PhD
  Paul W. Wong, PhD
  Hua Yang, MD, PhD

  ---

  Photo caption:  Timothy Olsen , MD, conducting research to reduce the severity of proliferative vitreoretinopathy.  

• Research News

  Emory Eye Center Faculty Receive Top ARVO Awards Feb. 9, 2012 | (ATLANTA) The Association for Research in Vision and Ophthalmology (ARVO) has announced this year's class of distinguished Fellows. Two Eye Center faculty members have been awarded the prestigious Gold Fellow status. Additionally, Henry F. Edelhauser, PhD, former director of research, will be honored at the ARVO Foundation for Eye Research (AFER) Gala Dinner for his lifetime of work in eye research. All three awards will take place during the spring national meeting in Florida.

  View all news

  Molecular Vision

  Molecular Vision is a peer-reviewed journal dedicated to the dissemination of research results in molecular biology, cell biology, and the genetics of the visual system (ocular and cortical).

Footer